Patients
Patients with tumors of the upper-third stomach who underwent LPG–DFT from January 2013 to June 2017 in the Department of Gastroenterological Surgery at the Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, were included in the study. Patients who underwent combined resection of other organs except for cholecystectomy were excluded. Additionally, patients with tumor with esophageal invasion which reached 3 cm above the esophago-gastric junction were also excluded from the study because they required resection of the abdominal esophagus. For each patient, surgery was either performed or supervised by five experts in laparoscopic surgery. All five surgeons introduced LPG–DFT at the same period. The extent of tumor depth (cT) and nodal involvement (cN) was determined by pre-operative evaluations, including barium radiography, upper gastrointestinal tract endoscopy, CT, and endoscopic ultrasonography, and were evaluated using the Japanese Classification of Gastric Carcinoma: 3rd edition [14]. According to the Japanese Gastric Cancer Treatment Guidelines 2014 (ver.4) [4], clinical Stage I gastric cancer located in the upper third of the stomach was the indication for LPG. Patients who were indicated for endoscopic resection underwent endoscopic submucosal dissection; however, patients with non-curative factors underwent additional surgical resection and were also included. Additionally, LPG was adapted for patients with symptomatic submucosal tumors and neuroendocrine neoplasms of the upper-third stomach, which required gastrectomy; these patients were also included.
Patients for whom LPG was indicated by pre-operative examinations underwent additional endoscopic examination to mark the distal margins by clips approximately 2 cm from the tumor, confirmed by biopsy to be negative for cancer. The proximal margins were also marked by clips in cases where the lesions had esophageal invasion. After marking, fluoroscopy of the stomach was performed to reveal the length of esophageal invasion, and to confirm that the size of the remnant stomach was large enough for a tension-free reconstruction.
Surgical procedure of LPG
Laparoscopic proximal gastrectomy was performed under a pneumoperitoneum that was created by the injection of carbon dioxide (10–12 mmHg). A total of five ports (each 5–12 mm) were inserted, and modified D1+ (node numbers 1, 2, 3a, 4sa, 4sb, 7, 8a, 9, and 11p) lymph node dissection was performed except for patients with submucosal tumors according to the Japanese Gastric Cancer Treatment Guidelines 2014 (ver. 4) [4], as previously described [13]. The hepatic branch of the anterior branch of the vagal nerve was preserved. Additionally, the celiac branch of the posterior vagal trunk was preserved when possible. The right gastric artery and the right gastroepiploic artery were also preserved. After lymph node dissection, intraoperative gastroscopy was performed for all patients to confirm the location of the tumor and the marking clips, and a safe gastric transection line was determined and marked with blue dye or by suturing in the outer gastric wall. The stomach was transected with endoscopic linear staplers. Intraoperative pathological examination of the proximal and/or distal margin by frozen section was performed for all patients except for patients after endoscopic treatment, to confirm negative margins. After reconstruction, an indwelling drain was placed along the upper edge of the pancreas.
Reconstruction by double-flap technique
Esophagogastrostomy with valvuloplasty by DFT was performed as previously reported [10,11,12, 15]. Briefly, double seromuscular flaps (2.5 cm wide and 3.5 cm high) were created at the anterior wall of the remnant stomach using an electric cautery. After creating the double flap, an incision was made at the inferior end of the mucosal window, and the superior end of the mucosal window of the stomach was fixed to the posterior wall of the esophagus 5 cm above the cut end. Then, the esophagus and the opened mucosa of the remnant stomach were anastomosed (Fig. 1). Seromuscular suture to reinforce the anastomosis was optional. Finally, the anastomotic site was fully covered with seromuscular flaps. Intraoperative gastroscopy was performed to confirm the appropriate tightness of the anastomosis.
Post-operative management
Fluoroscopy was performed on post-operative day (POD) 3 as a screening test for anastomotic complications and neo-cardiac function. The indwelling drain was usually removed on POD 3 or 4. Patients who recovered well were usually discharged after POD 9. Patients underwent endoscopic examination approximately 12 months after surgery to screen for anastomotic complications and recurrence. For the patients who developed symptoms of anastomotic stricture and reflux esophagitis, endoscopy was performed at an earlier date. Reflux esophagitis was classified according to the Los Angeles classification, whereas grade ≥ B cases were included. Post-operative anastomotic stricture was defined as the need for balloon dilatation, and details of balloon dilatation were also collected. Patients who were diagnosed as having pathological Stage II or III gastric cancer (except for patients with pT1 and pT3N0 tumors) underwent adjuvant chemotherapy on the basis of ACTS-GC trial [16, 17].
Statistical analysis
The data collected included patient background data, such as age; sex; height; weight; body mass index; history of abdominal surgery; history of pre-operative endoscopic treatment; presence or absence and the length of esophageal invasion; cT; cN; clinical Stage; surgical outcomes, such as operation time and intraoperative blood loss; presence or absence of simultaneous cholecystectomy; post-operative courses, such as post-operative complications and hospital stays; and results from pathological examinations. The long-diameter of the esophagus on pre-operative CT imaging was measured at the level of the crura of the diaphragm and was also collected (Fig. 2). In patients with complications, details of the complications and Clavien–Dindo (CD) classification grade were determined. All patients were followed up at the outpatient clinic for > 1 year, and late complications, including findings from the upper gastrointestinal endoscopy, were also reviewed.
Statistical analyses between the groups were performed using the Mann–Whitney U test and chi-squared test. In addition, multivariate binary logistic regression analysis, with the corresponding odds ratios (OR) and 95% confidence intervals (CI), was performed to identify independent risk factors for anastomotic stricture. All the statistical analyses were performed using Statistical Package for the Social Sciences, version 23.0 (SPSS, Chicago, IL, USA). A P value of < 0.05 was considered as indicative of statistical significance. Unless otherwise indicated, data were presented as the median and range. This study was a retrospective study conducted in accordance with the International Conference on Harmonization of Guidelines for Good Clinical Practice and approved by the Ethics Committee of the Cancer Institute Hospital of JFCR (approval number: 2017-1168). Treatment was performed after obtaining informed consent and patient approval. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.